India's biggest drugmaker Sun Pharmaceutical Industries on Friday posted a 266% jump in consolidated net profit to ₹2,034 crore for the quarter ended June. The firm's revenue increased 22% to ₹8,243 crore compared to the last year period. Further, Sun Pharma's tax expenses also increased more than three-fold to ₹352.7 crore against the previous year period.